glp 1 r GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes Central glucagon-like peptide 1 receptor

The absence of a head-to-head trial means that prescribing decisions will initially be guided by availability, formulary coverage, individual tolerability, and prescriber familiarity rather than definitive comparative efficacy data

Neuroprotective effects of eexenatide in a rotenone-induced rat model of Parkinsons disease

Furthermore, a higher dose of 400 mg/kg SAE resulted in a significant upregulation of CRYAA gene expression, a crucial factor in maintaining lens transparency and preventing cataract formation

2007 Jul 2;178(1):93105

Other conditions, such as acquired cystic disease and kidney cancer, are characterized by excess numbers of cyst wall and malignant cells, respectively